Corrigendum to 'Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials'. | Transplant Cell Ther;2023 Jul 05. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

BVS - MINISTÉRIO DA SAÚDE

Informação e Conhecimento para a Saúde

português

Localizar descritor de assunto Busca Avançada EVID@Easy

Corrigendum to 'Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials'.

Lin, Chenyu; Horwitz, Mitchell E.

Afiliação

Lin C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: mitchell.horwitz@duke.edu.

Transplant Cell Ther ; 2023 Jul 05.

Article em En | MEDLINE | ID: mdl-37421972

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article